483
Dexcom, Inc.FDA 483 - Dexcom, Inc.
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Dexcom, Inc. received a Form FDA-483 following an inspection of its San Diego facility from October 21 to November 7, 2024. The company is committed to addressing the identified concerns, which relate to quality management system processes, manufacturing controls, and product performance for its continuous glucose monitoring devices. Dexcom has outlined immediate actions and ongoing commitments to drive improvements across its manufacturing sites.
- Company
- Dexcom, Inc.
- Product Type
- Device
Open in Dashboard
ID · d19fd6fe-0cac-4e87-ac09-00ff141b0d77